can you take tirzepatide with thyroid issues vs. Semaglutide: What Should Know Tirzepatide - Injectable Peptide

Once in use, keep below 30 C and discard within the validated in-use window [1][2][3]

Tirzepatide, is the active ingredient in Mounjaro for type 2 diabetics and Zepbound for obesity treatment, is a dual glucose-dependent insulinotropic polypeptide (GIP) and a Glucagon-like peptide-1 (GLP-1) receptor agonist

However, there are critical distinctions: Rodents have a much higher density of GLP-1 receptors on thyroid C-cells than humans Human thyroid C-cells show minimal GLP-1 receptor expression No causal link between semaglutide and thyroid cancer has been established in human clinical trials involving over 10,000 participants (Bjerre Knudsen et al., 2010, Endocrinology ) A large pharmacovigilance study published in Diabetes Care found no increased risk of thyroid cancer among GLP-1 receptor agonist users compared to other diabetes medications (Bezin et al., 2023, Diabetes Care ) Despite this reassurance, the following patients should avoid semaglutide: Those with a personal history of medullary thyroid carcinoma (MTC) Those with a family history of MTC Patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) For patients with common hypothyroidism (typically Hashimotos thyroiditis or post-surgical hypothyroidism), these contraindications do not apply

In addition to the regulation of eNOS activity, Cav-1 also can modulate the activation of VEGFR2

With injections, people often experience faster results, especially when addressing issues like detoxification, oxidative stress, skin health, or inflammation management